Anionic nanoliposomes reduced atherosclerosis progression in Low Density Lipoprotein Receptor ( LDLR ) deficient mice fed a high fat diet-Reference-Cited by-同舟云学术

Anionic nanoliposomes reduced atherosclerosis progression in Low Density Lipoprotein Receptor ( LDLR ) deficient mice fed a high fat diet

Published:2018-05-09 Issue:10 Volume:233 Page:6951-6964
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Krishna Smriti M.¹^ORCID,Moxon Joseph V.¹,Jose Roby J.¹,Li Jiaze¹,Sahebkar Amirhossein²³⁴^ORCID,Jaafari Mahmoud R.⁵,Hatamipour Mahdi⁵,Liu Dawie¹,Golledge Jonathan¹⁶

Affiliation:

1. Queensland Research Centre for Peripheral Vascular Disease, College of Medicine and Dentistry James Cook University Townsville Queensland Australia

2. Biotechnology Research Center, Pharmaceutical Technology Institute Mashhad University of Medical Sciences Mashhad Iran

3. Neurogenic Inflammation Research Center Mashhad University of Medical Sciences Mashhad Iran

4. School of Pharmacy Mashhad University of Medical Sciences Mashhad Iran

5. Nanotechnology Research Centre, Pharmaceutical Technology Institute Mashhad University of Medical Sciences Mashhad Iran

6. Department of Vascular and Endovascular Surgery The Townsville Hospital Townsville Queensland Australia

Funder

Mashhad University of Medical Sciences

James Cook University

National Health and Medical Research Council

Queensland Government

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.26610

Reference52 articles.

1. Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRβ-deficient mice

2. Adenoviral expression of human lecithin-cholesterol acyltransferase in nonhuman primates leads to an antiatherogenic lipoprotein phenotype by increasing high-density lipoprotein and lowering low-density lipoprotein

3. Cell Association of Liposomes with High Fluid Anionic Phospholipid Content is Mediated Specifically by LDL and Its Receptor, LDLr

4. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

5. Phosphorus assay in column chromatography;Bartlett G. R.;The Journal of Biological Chemistry,1959

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral Nanoformulations in Cardiovascular Medicine: Advances in Atherosclerosis Treatment;Pharmaceuticals;2024-07-10

2. Magnetic nanoparticles and their hybrid biomaterials for drug delivery and theranostic applications in cardiovascular diseases;Journal of Drug Delivery Science and Technology;2024-06

3. Nanocarriers for the treatment of inflammatory diseases;Green Sustainable Process for Chemical and Environmental Engineering and Science;2023

4. Preclinical toxicity assessment of anionic nanoliposomes;Advanced Industrial and Engineering Polymer Research;2022-11

5. Negatively-charged Liposome Nanoparticles Can Prevent Dyslipidemia and Atherosclerosis Progression in the Rabbit Model;Current Vascular Pharmacology;2022-01